India’s new coronavirus infection (Corona 19) vaccine manufacturer, which was caught in the’controversial approval controversy’, was confident of the efficacy of the vaccine and began to dispel concerns.
According to local media such as Times of India on the 5th, Krishna Ella, chairman of Indian pharmaceutical company Barat Biotech, claimed in an online press conference the previous day that “the nose vaccine is 200% safe.”
COVaccine is a COVID-19 vaccine developed by Barat Biotech and was approved for emergency use by Indian authorities on the 3rd.
However, it was pointed out that the approval of the authorities is impatient because the clinical phase 3 trial is still in progress and the preventive effect of the nose vaccine has not been disclosed.
Accordingly, Chairman Ella refuted, saying that the side effects of co-vaccine are much less than that of other vaccines.
He emphasized that “we are a truly global company”, saying, “Clinics are in progress in 12 countries including the UK, Nepal, and Bangladesh.”
Chairman Ella said, “If you give me one week, I will provide reliable data,” he said. “The efficacy data of the last stage clinical trial will be secured in March.”
At the same time, it announced that it will produce 700 million doses (1 dose = 1 dose) of Corona 19 vaccine this year.
Chairman Ella explained that 20 million doses are currently being produced and that “200 million doses will be produced in Hyderabad and 500 million doses each in other cities.”
In this regard, the Minister of Health and Family Welfare Harsi Bardan also explained on the 3rd that it had been approved according to scientific grounds and procedures.
Minister Bardan argued that the co-vaccine using the inactivated virus is likely to have similar efficacy to other vaccines and that “it will respond better to the mutant virus.”
Indian authorities have approved the emergency use of the AstraZeneca vaccine along with the nose vaccine.
An official from the authorities told the Hindustan Times that “the vaccine will be distributed in stages from next weekend.”
In India, a total of 300 million people, including about 10 million medical and health workers and 20 million police, soldiers, and local government employees, have been designated as priority targets by the government.
Meanwhile, the cumulative number of corona 19 confirmed cases in India was 1,356,844 (based on the Ministry of Health and Family Welfare) on that day, an increase of 16,375 from the previous day.
The number of new confirmed cases per day, which reached 100,000 in September last year, has recently declined to around 20,000.
▶ Click here to enlarge
[연합뉴스]
Copyrights ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited